Quantity | Title | Price |
---|---|---|
1 × | Cytokeratin 5 + 8 antibody | €411,30 |
1 × | AFG3L2 antibody | €260,10 |
1 × | AP1B1 antibody | €260,10 |
1 × | TCFL4 antibody | €217,80 |
1 × | KLF11 antibody | €217,80 |
1 × | p39 antibody | €217,80 |
1 × | APC antibody | €209,70 |
1 × | SKP2 antibody | €217,80 |
1 × | AGAP2 antibody | €260,10 |
1 × | CD16 antibody (FITC) | €432,90 |
1 × | NEURL1 antibody | €217,80 |
1 × | Purified anti-mouse CD304 (Neuropilin-1) | €75,44 |
1 × | PTTG1/2/3 antibody | 0 |
1 × | ANXA9 antibody | 0 |
1 × | GFAP antibody | 0 |
1 × | APC anti-mouse CD301 (MGL1/MGL2) | 0 |
1 × | FXR2 antibody | 0 |
You are here
Products
C3d Polyclonal


Product group: | Primary |
Monoclonal/ Polyclonal: | Polyclonal |
Host: | Rabbit |
Isotype: | IgG |
Application: | Immunohistochemistry (IHC) |
Application notes: | 25-200 |
Conjugation Type: | Unconjugated |
Reactivity: | Human |
General notes: | Localization: membrane or cytoplasm. |
Buffer: | citrate pH6.0 or EDTA pH8.0 |
UNSPSC code: | 12352203 |
Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. C3d deposition in the renal transplant PTCs (peritubular capillaries) is indicative of AR (acute rejection) with subsequent high probability of graft loss. Anti-C3d, combined with anti-C4d, can be utilized as a tool for diagnosis of AR and warrant prompt and aggressive anti-rejection treatment. It was shown that anti-C3d labeled the epidermal basement membrane in 97% (31/32) cases of bullous pemphigoid (BP), with none of the normal controls demonstrating such findings. In the same study 27% (3/11) cases of pemphigus vulgaris (PV) demonstrated intercellular C3d deposition. Therefore, C3d immunohistochemistry is a helpful adjunct in the diagnosis of BP (and perhaps PV), especially in the cases in which only formalin-fixed, paraffin embedded tissue is available for analysis. (Shipping Cost: €200.00)
C3d Polyclonal
Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. C3d deposition in the renal transplant PTCs (peritubular capillaries) is indicative of AR (acute rejection) with subsequent high probability of graft loss. Anti-C3d, combined with anti-C4d, can be utilized as a tool for diagnosis of AR and warrant prompt and aggressive anti-rejection treatment. It was shown that anti-C3d labeled the epidermal basement membrane in 97% (31/32) cases of bullous pemphigoid (BP), with none of the normal controls demonstrating such findings. In the same study 27% (3/11) cases of pemphigus vulgaris (PV) demonstrated intercellular C3d deposition. Therefore, C3d immunohistochemistry is a helpful adjunct in the diagnosis of BP (and perhaps PV), especially in the cases in which only formalin-fixed, paraffin embedded tissue is available for analysis.
Alternative names: